Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F24%3A10487364" target="_blank" >RIV/00064203:_____/24:10487364 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11130/24:10487364

Výsledek na webu

<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=5Z60vLLn8r" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=5Z60vLLn8r</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1177/20420188241274363" target="_blank" >10.1177/20420188241274363</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication

Popis výsledku v původním jazyce

center dot For children with growth hormone deficiency, once-weekly somatrogon injections were less of a burden than once-daily somatropin injections. center dot The safety of weekly somatrogon was similar to that of daily somatropin. center dot Compared with daily somatropin injections, children with growth hormone deficiency may be less likely to miss weekly somatrogon injections. circle This is because weekly somatrogon injections were less of a burden and were less likely to interfere with daily activities compared with daily somatropin injections. The purpose of this plain language summary is to help you to understand the findings from recent research. center dot Somatrogon is used to treat the condition under study that is discussed in this summary. Approval varies by country; please check with your local provider for more details. center dot The results of this study may differ from those of other studies. Health professionals should make treatment decisions based on all available evidence and not on the results of a single study.

Název v anglickém jazyce

Understanding the burden of weekly somatrogon injections compared with daily somatropin injections in children with growth hormone deficiency: a plain language summary of publication

Popis výsledku anglicky

center dot For children with growth hormone deficiency, once-weekly somatrogon injections were less of a burden than once-daily somatropin injections. center dot The safety of weekly somatrogon was similar to that of daily somatropin. center dot Compared with daily somatropin injections, children with growth hormone deficiency may be less likely to miss weekly somatrogon injections. circle This is because weekly somatrogon injections were less of a burden and were less likely to interfere with daily activities compared with daily somatropin injections. The purpose of this plain language summary is to help you to understand the findings from recent research. center dot Somatrogon is used to treat the condition under study that is discussed in this summary. Approval varies by country; please check with your local provider for more details. center dot The results of this study may differ from those of other studies. Health professionals should make treatment decisions based on all available evidence and not on the results of a single study.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30209 - Paediatrics

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Therapeutic Advances in Endocrinology and Metabolism

ISSN

2042-0188

e-ISSN

2042-0196

Svazek periodika

15

Číslo periodika v rámci svazku

November

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

20420188241274363

Kód UT WoS článku

001346952400001

EID výsledku v databázi Scopus

2-s2.0-85208781925